Abstract
CNPase (2',3'-Cyclic-nucleotide 3'-phosphodiesterase) is showing promising potential in being a protein biomarker for the mental illness schizophrenia, due to a modified expression pattern in schizophrenia patients. This condition affects around 0.5% of the population, leading to a range of symptoms that impair the ability to be self-sufficient and mesh with society, and is only currently…